MedTrace Logo

Risk Factors of Porphyria Cutanea Tarda (PCT)

NCT00213772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2005-09-21

No results posted yet for this study

Summary

Comparison of patients with documented PCT and HCV infection, documented PCT without HCV, HCV infection without PCT and controls without HCV or PCT.

Single blood + urine sample uptake to investigate : mutations in HFE gene, uroporphyrinogen decarboxylase activity, HCV genotye, history of disease.

Conditions

  • Porphyria Cutanea Tarda

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Bernard Cribier, MD · Hopitaux Universitaires de Strasbourg

  • O. Chosidow, MD · Hopital Pitié-Salpétrière / Paris

  • M. Bagot, MD · Hopital Henri Mondor / CHU Créteil

  • J.P Lacour, MD · Hopital de l'Archet / CHU Nice

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00213772 on ClinicalTrials.gov